Lindonlight Collective

Honoring Dr. Martin Luther King Jr. Today, we reflect on the legacy of Dr. Martin Luther King Jr. and his unwavering pursuit of justice, equality, and peace. His vision continues to inspire us to build a more inclusive and equitable future. At Lindonlight Collective, we remain committed to fostering innovation and breaking barriers in pursuit of meaningful change. #MLKDay #Equality #Inspiration #LindonlightCollective

✨ Collaboration Beyond the Conference Room ✨ After an incredibly productive day-long retreat, bringing together experts from the University of California, San Francisco, and MD Anderson Cancer Center, the Lindonlight Collective team ended the evening with a dinner to celebrate this groundbreaking collaboration. Discussions from the day continued around the table as we united over a shared vision: advancing research and treatment options for pediatric brain cancer patients. Moments like these remind us that impactful science is built on strong partnerships and shared commitment. A heartfelt thank you to all who participated in this momentous retreat—we’re excited to move forward together in this important work. #Collaboration #PediatricCancerResearch #Teamwork #LindonlightCollective

🌟 Employee Spotlight: Florian Muller, PhD 🌟 At Lindonlight Collective, we are proud to have a team driven by passion and purpose, and today, we are excited to highlight Florian Muller, PhD, our Chief Scientific Officer. Florian’s dedication to advancing cutting-edge research in pediatric brain cancer is nothing short of inspiring. With a remarkable career spanning over 20 years, Florian leads our scientific efforts with expertise, vision, and an unwavering commitment to innovation. We are grateful to have Florian’s leadership and scientific acumen guiding Lindonlight’s mission to enable impactful research and drive meaningful change. Join us in celebrating Florian’s contributions to science and our mission! 👏 #TeamSpotlight #PediatricCancerResearch #Innovation #LindonlightCollective

🎁 Celebrating the Holidays, Lindonlight Style 🎀 Last night, the Lindonlight Collective team gathered for our rescheduled holiday dinner, and it was a truly special evening. One memorable highlight was the thoughtfully curated gifts from our COO, Brittany Parker Kerrigan, PhD. Each gift—and even the unique wrapping paper—was chosen to reflect something meaningful about each team member. This attention to detail and care embodies the values we hold dear as a team: connection, appreciation, and thoughtfulness. We’re grateful to work alongside such an incredible group of people who are not only passionate about advancing pediatric brain cancer research but also about fostering a supportive and collaborative culture. Here’s to carrying this spirit into 2025 and beyond! 💙 #TeamCulture #Gratitude #Leadership #HolidayCelebration

🎉 Happy New Year from Lindonlight Collective! 🎉 As we welcome 2025, we’re filled with hope, determination, and excitement for what lies ahead. This past year has been one of incredible progress, made possible by our dedicated team, brilliant collaborators, and supportive community. Here’s to a year of innovation, collaboration, and breakthroughs. Thank you for being part of this journey! 💙 Cheers to 2025! #HappyNewYear #LindonlightCollective #Hope #Innovation

✨ Reflecting on Progress, Empowering the Future ✨ As the year comes to a close, we at Lindonlight Collective are reflecting on the strides made toward advancing research for pediatric brain cancer. From forging new collaborations to funding groundbreaking projects, every step has brought us closer to our shared goal of a brighter future for children and families. We're deeply grateful for our partners, researchers, and supporters who fuel this journey with unwavering dedication. Together, we’re not just advancing science; we’re changing lives. #LindonlightCollective #PediatricCancerResearch #Celebrating2024

Happy Holidays from Lindonlight Collective! May this holiday season bring joy, warmth, and moments of reflection for all. We look forward to continuing our mission in the new year, fueled by hope and determination.

As the year draws to a close, we want to take a moment to express our heartfelt gratitude to the incredible team at Lindonlight Collective. 💙 Your passion, dedication, and unwavering commitment to advancing pediatric brain cancer research inspire us every day. From groundbreaking ideas to the day-to-day work that fuels our mission, every effort you make brings us closer to transforming the lives of children and families. Here’s to the amazing progress we’ve made together in 2024 and to all the incredible achievements yet to come in 2025. We’re so proud to have such talented and driven individuals as part of our journey. Thank you for making Lindonlight Collective a force for hope, innovation, and change. 🌟 #TeamLindonlight #Thankful #PediatricBrainCancerResearch #Innovation #LindonlightCollective

🌟 Advancing Pediatric Brain Cancer Research 🌟 We are proud to announce that Lindonlight Collective has awarded $1.97 million to Dr. Petra Hamerlik at the The University of Manchester for her pioneering work on pediatric low-grade gliomas. 🧬 About the Project: Dr. Hamerlik’s research will develop 3D spheroid cultures and patient-derived models to enable more accurate preclinical drug testing and aid in biomarker discovery. This critical work bridges a major gap in pediatric brain cancer research and brings us closer to improved treatments for children. #PediatricCancerResearch #BrainCancer #PreclinicalModels #ResearchFunding #LindonlightCollective #InnovationInScience #Gliomas

Daiichi Sankyo is deeply saddened by the passing of Dr. Toshinori Agatsuma, Executive Officer, Head of Research, Daiichi Sankyo, who passed away on December 5, 2024. A true scientific innovator in every sense of the word, Dr. Agatsuma leaves an immeasurable legacy on the global oncology community as a pioneer of hope for countless people impacted by cancer. His patience, scientific expertise and compassionate leadership altered the trajectory of Daiichi Sankyo into a company with competitive advantage in oncology.     We invite you to learn more about the life and legacy Dr. Agatsuma and the profound impact he had on patients around the world. Company website statement: https://bit.ly/3ZrhDN0 Pursuing Anticancer Drug Possibilities: https://bit.ly/3ZFVo7e  Dr. Agatsuma’s Story: https://bit.ly/4ghBODO   Q&A on Japan Bioindustry Award: https://bit.ly/4fWJ4FB     Dr. Agatsuma's pursuit to transform science into medicine has helped make the world a better place and will benefit the patients of today, tomorrow and beyond. We send our deepest condolences to his family.